FAQ: Corticosteroids And Hormonal Therapies — History, Use & Future Outlook

Corticosteroids and hormonal therapies have shaped modern medicine for decades, underpinning treatments for respiratory disease, autoimmune disorders, diabetes, thyroid conditions, and many other chronic illnesses. Originally emerging from breakthroughs in endocrinology and adrenal hormone research, these therapies have evolved alongside scientific understanding of immune regulation and metabolic control. Today, they are delivered across diverse dosage forms and increasingly supported by advances in formulation science, recombinant technologies, and digital health tools.

At the same time, global demand continues to expand. Rising rates of chronic and endocrine diseases, broader healthcare access in emerging markets, and ongoing innovation in targeted and personalized treatments are reshaping both clinical practice and commercial landscapes. From next-generation selective steroid molecules to wearable and digitally enabled endocrine solutions, the field is entering a new phase of refinement and growth.

As markets scale and therapies become more sophisticated, new scientific, regulatory, and manufacturing considerations are emerging — setting the stage for the next chapter in these essential treatment categories.